“…Acellular tissue ECM scaffolds are natural biological biomaterials with effective removal of cell components which are supposed to have immunogenicity to the host, while retaining the naturally occurring three‐dimensional (3D) structure with tissue‐specific origins of ECM structural proteins (collagens and elastin), specialized proteins (fibrillin, fibronectin, and laminin), proteoglycans (glycosaminoglycan, heparin sulfate, and chondroitin sulfate), and growth factors which are hard to be created synthetically (Cheng, Solorio, & Alsberg, ; Gupta, Mishra, & Dhasmana, ). So far, acellular tissue materials used for GBR include human dermal (Borges et al, ; de Andrade et al, ; Momen‐Heravi, Peters, Garfinkle, & Kang, ), human amnion (Li et al, ), bovine pericardium (Bai et al, ), and porcine pericardium (Hwang, Kim, Kim, & Lee, ) out of which only acellular dermal are put into clinical use, and others are still in preclinical research stages. Although tissue‐derived ECM materials are commonly used to repair non‐homologous anatomic sites, materials derived from site‐specific homologous tissues have been suggested to be more helpful for constructive tissue remodeling as compared to nonsite‐specific tissue sources (Zhang et al, ).…”